Hoodin (HOODIN) Q3 2024 earnings summary

Executive summary

• Strategic transformation towards AI leadership in regulatory affairs and quality assurance for life science sector initiated in Q3 2024.

• Expanded AI components in the platform and deepened partnerships with QMS providers to enhance integrated solutions.

• Signed a partner agreement with MedoQi to drive expansion in the Asian market post-period.

Financial highlights

• Q3 2024 net revenue was 243 KSEK, unchanged from Q3 2023; operating loss improved to -1,072 KSEK from -1,444 KSEK year-over-year.

• Net loss for Q3 2024 was -1,072 KSEK, with EPS at -0.02 SEK, compared to -1,443 KSEK and -0.05 SEK in Q3 2023.

• Nine-month 2024 net revenue reached 723 KSEK (711 KSEK in 2023); operating loss narrowed to -3,680 KSEK from -4,666 KSEK.

• Cash flow from operations for Q3 was -1,076 KSEK, an improvement from -1,370 KSEK in Q3 2023; cash at period end was 3,226 KSEK.

• Equity at period end was 5,544 KSEK, down from 13,185 KSEK a year earlier.

Outlook and guidance

• Anticipates continued growth in demand for digital surveillance and vigilance solutions in life science and other sectors.

• Expects long sales cycles, especially among Medtech clients, to delay revenue recognition despite positive market developments.

• Ongoing global uncertainties, inflation, and interest rates are seen as potential risks but also as drivers for digitalization and efficiency.